VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. Financials - Benzinga

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc.

VRPXOTCEM

Trade with Public

Trade with Public

$0.00010

At close: Sep 11, 5:00 PM EST

Overview News Earnings Forecast Price TargetsFinancialsSentiment Ownership Compare

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. Financials

VIRPAX PHARMS INC by Virpax Pharmaceuticals, Inc. (VRPX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Virpax Pharmaceuticals Q2 2024 GAAP EPS $(1.75) May Not Be Comparable To $(0.61) Estimate

Benzinga Newsdesk

Nasdaq Gains 1%; LegalZoom Shares Slide

Avi Kapoor

Nasdaq Surges 100 Points; Manchester United Shares Rise After Q3 Results

Avi Kapoor

Gold Rises Over 1%; Arcos Dorados Shares Fall After Q1 Results

Avi Kapoor

Nasdaq Surges 150 Points; Retail Sales Flat For April

Avi Kapoor

Dow Jumps 200 Points; US Inflation Rate Slows In April

Avi Kapoor